The primary efficacy of Centella Asiatica Extract is centered on skin repair and anti-inflammatory actions. Its key active components, such as asiaticoside and madecassoside, are known for promoting wound healing and scar removal by activating basal layer cell proliferation and encouraging the formation of normal granulation tissue. 

It also inhibits the proliferation of fibroblasts, which helps to suppress and delay the disordered proliferation of scar tissue.

Furthermore, it exhibits significant antioxidant properties, capable of inhibiting free radical activity, lightening pigmentation, improving skin blood circulation, and renewing skin cell regeneration to aid in the metabolism of melanin, resulting in smoother and brighter skin.

Guilin TECA Ingredient Corp. was founded in 2018, highly engaged in the production and sales of Centella Asiatica Extract. The company is located in the National High-tech Zone University Science and Technology Park, Qixing District, Guilin City, Guangxi Province, which is a national high-tech enterprise with import and export rights. At present, there are more than 20 employees. 

Our company specializes in producing a full range of specifications of Centella Asiatica Extract, which is mainly used in the cosmetics industry. After years of efforts, our main product Centella Asiatica Extract sales is in the top level of the Centella Extraction industry,  in China.

Our company has 5 botanical chemical engineers for the development of extracts, all of whom have more than 20 years of technical research and development and production experience, and are proficient in the research and development of natural products, composite technology and production management. The company has a complete large modern professional factory and advanced plant extraction, separation and purification equipments. The company has developed a number of independent intellectual property rights, greatly improving production efficiency. Our   existing property rights patents are "A process for extracting madecassoside from Centella Asiatica leaves" (patent number: CN106977579B) and "A method for extracting asiatic acid from Centella Asiatica leaves" (patent number: CN106349320B).